Efficacy and safety of amrubicin after treatment with immune checkpoint inhibitor combined with chemotherapy in extensive-stage small cell carcinoma: MiSSION1

被引：0
|
作者：
Nishimura, T. [1 ]
Fujimoto, H. [2 ]
Fujiwara, T. [2 ]
Ito, K. [3 ]
Fujiwara, A. [4 ]
Yuda, H. [5 ]
Itani, H. [6 ]
D'Alessandro-Gabazza, C. N. [7 ]
Gabazza, E. C. [7 ]
Kobayashi, T. [2 ]
机构：
[1] Mie Chuo Med Ctr, Resp Med, Tsu, Mie, Japan
[2] Mie Univ, Pulm & Crit Care Med, Fac & Grad Sch Med, Tsu, Mie, Japan
[3] Matsusaka City Hosp, Resp Ctr Dept, Matsusaka, Japan
[4] Mie Prefectural Gen Med Ctr, Pulm Med, Yokaichi, Japan
[5] Kuwana City Med Ctr, Pulm Med, Kuwana, Japan
[6] Ise Red Cross Hosp, Resp Med, Ise, Japan
[7] Mie Univ, Fac & Grad Sch Med, Immunol, Tsu, Mie, Japan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1630
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1535P
引用
收藏
页码：S1249 / S1249
页数：1
相关论文
共 50 条
  • [1] Efficacy of amrubicin after immuno-chemotherapy for extensive-stage small-cell lung cancer
    Ushio, Ryota
    Saito, Haruhiro
    Kato, Teruhumi
    Kondo, Tetsuro
    Murakami, Shuji
    Katakura, Seigo
    Shinada, Kanako
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S544 - S544
  • [2] Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy
    Nishimura, Tadashi
    Fujimoto, Hajime
    Fujiwara, Takumi
    Ito, Kentaro
    Fujiwara, Atsushi
    Yuda, Hisamichi
    Itani, Hidetoshi
    Naito, Masahiro
    Kodama, Shuji
    Yagi, Akihiko
    D'Alessandro, Valeria Fridman
    Yasuma, Taro
    Furuhashi, Kazuki
    Saiki, Haruko
    Okano, Tomohito
    Tomaru, Atsushi
    Tanigawa, Motoaki
    D'Alessandro-Gabazza, Corina N.
    Gabazza, Esteban C.
    Yoshida, Masamichi
    Hataji, Osamu
    Ibata, Hidenori
    Kobayashi, Tetsu
    [J]. CANCERS, 2022, 14 (16)
  • [3] The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Extrapulmonary Small Cell Carcinoma
    Aly, Ragia
    Gupta, Sachin
    Potdar, Rashmika
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [4] Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)
    Xiaoting Ma
    Shan Wang
    Yujian Zhang
    Huamin Wei
    Jing Yu
    [J]. Journal of Cancer Research and Clinical Oncology, 2021, 147 : 593 - 606
  • [5] Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)
    Ma, Xiaoting
    Wang, Shan
    Zhang, Yujian
    Wei, Huamin
    Yu, Jing
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (02) : 593 - 606
  • [6] Efficacy and safety of first-line immune checkpoint inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: A network meta -analysis
    Wang, Shuxing
    Li, Yunshu
    Liu, Zhuqing
    Tian, Wentao
    Zeng, Yue
    Liu, Junqi
    Zhang, Sujuan
    Peng, Yurong
    Wu, Fang
    [J]. LUNG CANCER, 2023, 178 : 47 - 56
  • [7] Immune checkpoint inhibitors in extensive-stage small cell lung cancer
    Zhang, Tongmei
    [J]. JOURNAL OF THE NATIONAL CANCER CENTER, 2022, 2 (03): : 130 - 131
  • [8] Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy in patients with extensive-stage small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials
    Chen, Chunlan
    Tian, Peng
    Zhong, Jiangshan
    Fan, Xianming
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a meta-analysis based on mixed-effect models
    Zheng, Jianqing
    Deng, Yujie
    Huang, Bifen
    Chen, Xiaohui
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [10] Efficacy of EP chemotherapy followed by IP chemotherapy combined with radiotherapy in the treatment of extensive-stage small-cell lung cancer
    Kiang, Shiyang
    Ou, Chaopeng
    Xue, Ruifeng
    Zeng, Weian
    Huang, Jingxiu
    Zhang, Yingjun
    Chen, Dongtai
    Lai, Jielan
    [J]. JOURNAL OF BUON, 2021, 26 (02): : 306 - 312
12345